Publications
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy2018 | Second Faculty of Medicine
- Trial Watch-Immunostimulation with cytokines in cancer therapy2016 | Second Faculty of Medicine
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy2016 | Second Faculty of Medicine
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications2015 | Second Faculty of Medicine
- Combinatorial strategies for the induction of immunogenic cell death2015 | Second Faculty of Medicine
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death2015 | Second Faculty of Medicine
- Trial watch: Dendritic cell-based anticancer therapy2014 | Second Faculty of Medicine
- Trial Watch Dendritic cell-based interventions for cancer therapy2013 | Second Faculty of Medicine
- Type I interferon and cancer2024 | Second Faculty of Medicine
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...
